ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,419Medicare Part D Prescriptions Filled, Including Refills

Rank: 257 out of 972

$579K Total Retail Price of All Prescriptions

Rank: 240 out of 972

400 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,277 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 449 362 1 1
FUROSEMIDE 417 341 2 7
SIMVASTATIN 411 363 3 2
LEVOTHYROXINE SODIUM 366 327 4 3
OMEPRAZOLE 297 182 5 5
TRAMADOL HCL 269 212 6 15
GABAPENTIN 264 216 7 14
ALENDRONATE SODIUM 257 209 8 27
CITALOPRAM HBR 215 173 9 19
METOPROLOL TARTRATE 212 184 10 9
HYDROCODONE-ACETAMINOPHEN 187 141 S3 11 6
METFORMIN HCL 167 111 12 8
AMLODIPINE BESYLATE 166 150 13 4
HYDROCHLOROTHIAZIDE 164 154 14 10
NAMENDA 136 132 15 38
CARVEDILOL 133 110 16 21
DONEPEZIL HCL 131 128 17 26
WARFARIN SODIUM 130 130 18 12
LOSARTAN POTASSIUM 129 114 19 17
SERTRALINE HCL 122 93 20 25
ATORVASTATIN CALCIUM 120 105 21 11
POTASSIUM CHLORIDE 120 96 21 13
FENOFIBRATE 99 69 23 66
PRAVASTATIN SODIUM 97 74 24 20
ZOLPIDEM TARTRATE 95 90 25 23
TRAZODONE HCL 95 80 25 35
CYCLOBENZAPRINE HCL 94 44 R 27 53
ROPINIROLE HCL 94 90 27 72
GLIPIZIDE ER 85 63 29 103
PANTOPRAZOLE SODIUM 81 66 30 41
TRICOR 72 34 31 91
METOPROLOL SUCCINATE 72 63 31 16
CIPROFLOXACIN HCL 72 61 31 63
CRESTOR 70 42 34 33
GLIPIZIDE 69 63 35 59
AZITHROMYCIN 68 56 36 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 51 37 32
AMOXICILLIN 67 56 37 121
MIRTAZAPINE 66 40 39 46
PROAIR HFA 62 24 40 47
POLYETHYLENE GLYCOL 3350 61 54 41 67
CYMBALTA 60 34 42 49
MELOXICAM 58 42 43 36
ISOSORBIDE MONONITRATE ER 55 48 44 43
ALLOPURINOL 52 52 45 28
ADVAIR DISKUS 52 26 45 45
ZETIA 52 37 45 79
PLAVIX 51 49 48 55
NEXIUM 51 43 48 30
TAMSULOSIN HCL 50 49 50 29
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 50 61
FENTANYL 50 35 S2 50 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.